Clinical Trials · NCT07729332
Switching to Oral Weight Management Pharmacotherapy to Prevent Weight Regain After GLP-1 Therapy Discontinuation
- Phase
- Phase 4
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Massachusetts General Hospital
- Enrollment
- 60
- Start date
- Nov 2026
- Locations
- 1 site, United States
- Primary endpoint
- Percent change in body weight